Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies
Haematological malignancies result from a heterogeneous mix of genetic mutations and
chromosome aberrations and translocations. Targeted therapies, such as the anti‐CD20 …
chromosome aberrations and translocations. Targeted therapies, such as the anti‐CD20 …